drugset / Trial / NCT02815787
The Drug -Drug Interaction of SP2086 and Glyburide
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to investigate the potential interaction between SP2086 and Glyburide after the singe and multiple oral doses treatment in healthy adult volunteers respectively.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glyburide | Small molecule | 5 mg | Oral |
| Comparator | Glyburide | Small molecule | 200 mg | Oral |
| Comparator | Retagliptin | Small molecule | 200 mg | Oral |